PneumoWave

PneumoWave is a digital health company founded in 2018, focused on developing advanced respiratory monitoring solutions. The company combines proprietary sensor technology with AI-driven digital therapeutic software to enable real-time, remote monitoring of patients with respiratory conditions. This technology allows for continuous tracking of respiratory rates and performance outside of hospital settings, helping doctors optimize medication use and detect early signs of respiratory deterioration. PneumoWave's core products include a custom-designed, chest-worn biosensor and two key solutions: DCM, an activity monitor that tracks physical movement, and ALERT, which monitors for life-threatening respiratory events like opioid-induced respiratory depression. The company aims to facilitate timely medical interventions and shift patient care towards prevention and early treatment. Headquartered in the United Kingdom, with offices in the United States, PneumoWave serves patients with respiratory conditions, healthcare providers, and medical professionals. Their innovative wearable solutions enhance patient care through remote data collection and early intervention capabilities.

• Employees 22
• Founded 2018
• Annual Revenue $3500000
• Total Funding $12688999